Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9512111 | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | Gary D. Glick, Peter L. Toogood, Arthur Glenn Romero, Chad A. Van Huis, Thomas D. Aicher +5 more | 2016-12-06 |
| 9133122 | Amide compounds, compositions and uses thereof | Zhi-Liang Wei, Sumithra Gowlugari, Zhan Wang, Yeyu Cao, John Kincaid | 2015-09-15 |
| 8946439 | Amide compounds, compositions and uses thereof | Zhi-Liang Wei, Sumithra Gowlugari, Zhan Wang, Yeyu Cao, John Kincaid | 2015-02-03 |
| 8859545 | Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases | Michael G. Kelly, John Kincaid | 2014-10-14 |
| 8779144 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | Michael G. Kelly, John Kincaid, Yunfeng Fang, Yeyu Cao, Sumithra Gowlugari | 2014-07-15 |
| 8653091 | Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof | Zhi-Liang Wei, John Kincaid, Michael G. Kelly, Donogh John Roger O'Mahony | 2014-02-18 |
| 8546579 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | Michael G. Kelly, John Kincaid, Yunfeng Fang, Yeyu Cao, Sumithra Gowlugari +1 more | 2013-10-01 |
| 8093265 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | Michael G. Kelly, John Kincaid, Yunfeng Fang, Yeyu Cao, Sumithra Gowlugari +1 more | 2012-01-10 |
| 7816371 | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof | Michael G. Kelly, John Kincaid, Yunfeng Fang, Yeyu Cao, Sumithra Gowlugari +1 more | 2010-10-19 |
| 7745451 | Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions | Michael G. Kelly, John Kincaid | 2010-06-29 |
| 7576099 | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same | Michael G. Kelly, John Kincaid, Matthew Duncton, Kiran Sahasrabudhe, Satyanarayana Janagani +4 more | 2009-08-18 |